Carolyn Sartor, MD | Authors

785 FOERSTER ST

Articles

Commentary (Sartor): Emerging Role of EGFR-Targeted Therapies and Radiation in Head and Neck Cancer

December 01, 2004

The past several years have seenthe fruition of a new era in cancertherapy-targeted approachesusing biologic modifiers.However, as the clinical experiencewith novel inhibitors grows, some ofthe premises on which the treatmentswere designed are being challenged,and clinical findings are leading to newparadigms. Drs. Song and Raben providea forward-thinking review of thestatus of epidermal growth factor receptor(EGFR)-targeted therapy in headand neck cancer, a paper that serves toboth highlight progress and raise issuesthat continue to challenge the implementationof targeted therapy.